Loading...
Koninklijke Philips N.V.
PHG•NYSE
Healthcare
Medical - Devices
$24.02
$0.10(0.44%)
Koninklijke Philips N.V. (PHG) Financial Performance & Statements
Review Koninklijke Philips N.V.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-0.81%
↓ 0.81%
Operating Income Growth
560.00%
↑ 560.00%
Net Income Growth
-50.64%
↓ 50.64%
Operating Cash Flow Growth
-26.54%
↓ 26.54%
Operating Margin
8.38%
↑ 8.38%
Gross Margin
43.42%
↑ 43.42%
Net Profit Margin
2.07%
↑ 2.07%
ROE
3.14%
↑ 3.14%
ROIC
7.38%
↑ 7.38%
Koninklijke Philips N.V. (PHG) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Koninklijke Philips N.V. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.04B | $4.38B | $4.46B | $4.14B |
| Cost of Revenue | $3.08B | $2.37B | $2.47B | $2.32B |
| Gross Profit | $1.96B | $2.006B | $1.99B | $1.81B |
| Gross Profit Ratio | $0.39 | $0.46 | $0.45 | $0.44 |
| R&D Expenses | $472.00M | $433.00M | $424.00M | $419.00M |
| SG&A Expenses | $1.32B | $1.23B | $1.28B | $1.23B |
| Operating Expenses | $1.76B | $1.67B | $1.17B | $2.64B |
| Total Costs & Expenses | $4.84B | $4.04B | $3.65B | $4.96B |
| Interest Income | $5.00M | $34.00M | $20.00M | $24.00M |
| Interest Expense | $57.00M | $104.00M | $88.00M | $94.00M |
| Depreciation & Amortization | $0.00 | $14.00M | $319.00M | $177.50M |
| EBITDA | $172.00M | $351.00M | $744.00M | -$645.50M |
| EBITDA Ratio | $0.03 | $0.08 | $0.17 | -$0.16 |
| Operating Income | $200.00M | $337.00M | $816.00M | -$824.00M |
| Operating Income Ratio | $0.04 | $0.08 | $0.18 | -$0.20 |
| Other Income/Expenses (Net) | -$85.00M | -$90.00M | -$160.00M | -$70.00M |
| Income Before Tax | $115.00M | $247.00M | $656.00M | -$894.00M |
| Income Before Tax Ratio | $0.02 | $0.06 | $0.15 | -$0.22 |
| Income Tax Expense | $449.00M | $65.00M | $345.00M | $105.00M |
| Net Income | -$335.00M | $181.00M | $451.00M | -$999.00M |
| Net Income Ratio | -$0.07 | $0.04 | $0.10 | -$0.24 |
| EPS | -$0.36 | $0.20 | $0.50 | -$1.10 |
| Diluted EPS | -$0.36 | $0.20 | $0.50 | -$1.10 |
| Weighted Avg Shares Outstanding | $933.37M | $902.43M | $903.15M | $906.03M |
| Weighted Avg Shares Outstanding (Diluted) | $933.37M | $913.08M | $910.66M | $906.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan